169 related articles for article (PubMed ID: 27553285)
1. Decreased cruzipain and gp85/trans-sialidase family protein expression contributes to loss of Trypanosoma cruzi trypomastigote virulence.
San Francisco J; Barría I; Gutiérrez B; Neira I; Muñoz C; Sagua H; Araya JE; Andrade JC; Zailberger A; Catalán A; Remonsellez F; Vega JL; González J
Microbes Infect; 2017 Jan; 19(1):55-61. PubMed ID: 27553285
[TBL] [Abstract][Full Text] [Related]
2.
San Francisco J; Astudillo C; Vega JL; Catalán A; Gutiérrez B; Araya JE; Zailberger A; Marina A; García C; Sanchez N; Osuna A; Vilchez S; Ramírez MI; Macedo J; Feijoli VS; Palmisano G; González J
Virulence; 2022 Dec; 13(1):1827-1848. PubMed ID: 36284085
[TBL] [Abstract][Full Text] [Related]
3. Inactive
Pascuale CA; Burgos JM; Postan M; Lantos AB; Bertelli A; Campetella O; Leguizamón MS
Front Cell Infect Microbiol; 2017; 7():430. PubMed ID: 29046868
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease.
Chuenkova M; Pereira ME
J Exp Med; 1995 May; 181(5):1693-703. PubMed ID: 7722448
[TBL] [Abstract][Full Text] [Related]
5. Virulence in Trypanosoma cruzi infection correlates with the expression of a distinct family of sialidase superfamily genes.
Weston D; Patel B; Van Voorhis WC
Mol Biochem Parasitol; 1999 Jan; 98(1):105-16. PubMed ID: 10029313
[TBL] [Abstract][Full Text] [Related]
6. Comparative transcriptome profiling of virulent and non-virulent Trypanosoma cruzi underlines the role of surface proteins during infection.
Belew AT; Junqueira C; Rodrigues-Luiz GF; Valente BM; Oliveira AER; Polidoro RB; Zuccherato LW; Bartholomeu DC; Schenkman S; Gazzinelli RT; Burleigh BA; El-Sayed NM; Teixeira SMR
PLoS Pathog; 2017 Dec; 13(12):e1006767. PubMed ID: 29240831
[TBL] [Abstract][Full Text] [Related]
7.
Chain CY; Pires Souto DE; Sbaraglini ML; Labriola CA; Daza Millone MA; Ramirez EA; Cisneros JS; Lopez-Albizu C; Scollo K; Kubota LT; Ruiz AM; Vela ME
ACS Infect Dis; 2019 Nov; 5(11):1813-1819. PubMed ID: 31538468
[No Abstract] [Full Text] [Related]
8. Molecular basis of non-virulence of Trypanosoma cruzi clone CL-14.
Atayde VD; Neira I; Cortez M; Ferreira D; Freymüller E; Yoshida N
Int J Parasitol; 2004 Jun; 34(7):851-60. PubMed ID: 15157768
[TBL] [Abstract][Full Text] [Related]
9. Role of the gp85/trans-sialidases in Trypanosoma cruzi tissue tropism: preferential binding of a conserved peptide motif to the vasculature in vivo.
Tonelli RR; Giordano RJ; Barbu EM; Torrecilhas AC; Kobayashi GS; Langley RR; Arap W; Pasqualini R; Colli W; Alves MJ
PLoS Negl Trop Dis; 2010 Nov; 4(11):e864. PubMed ID: 21072227
[TBL] [Abstract][Full Text] [Related]
10. Sialylated ligands on pathogenic Trypanosoma cruzi interact with Siglec-E (sialic acid-binding Ig-like lectin-E).
Erdmann H; Steeg C; Koch-Nolte F; Fleischer B; Jacobs T
Cell Microbiol; 2009 Nov; 11(11):1600-11. PubMed ID: 19552697
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages.
Risso MG; Garbarino GB; Mocetti E; Campetella O; Gonzalez Cappa SM; Buscaglia CA; Leguizamon MS
J Infect Dis; 2004 Jun; 189(12):2250-9. PubMed ID: 15181573
[TBL] [Abstract][Full Text] [Related]
12. Invasive phenotype of Trypanosoma cruzi restricted to a population expressing trans-sialidase.
Pereira ME; Zhang K; Gong Y; Herrera EM; Ming M
Infect Immun; 1996 Sep; 64(9):3884-92. PubMed ID: 8751943
[TBL] [Abstract][Full Text] [Related]
13. Trans-sialidase overcomes many antigens to be used as a vaccine candidate against Trypanosoma cruzi.
Bontempi I; Fleitas P; Poato A; Vicco M; Rodeles L; Prochetto E; Cabrera G; Beluzzo B; Arias D; Racca A; Guerrero S; Marcipar I
Immunotherapy; 2017 Jun; 9(7):555-565. PubMed ID: 28595515
[TBL] [Abstract][Full Text] [Related]
14. Sequence diversity of the Trypanosoma cruzi complement regulatory protein family.
Beucher M; Norris KA
Infect Immun; 2008 Feb; 76(2):750-8. PubMed ID: 18070905
[TBL] [Abstract][Full Text] [Related]
15. Parasite-host glycan interactions during Trypanosoma cruzi infection: trans-Sialidase rides the show.
Campetella O; Buscaglia CA; Mucci J; Leguizamón MS
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165692. PubMed ID: 31972227
[TBL] [Abstract][Full Text] [Related]
16. Exploring the FL-160-CRP gene family through sequence variability of the complement regulatory protein (CRP) expressed by the trypomastigote stage of Trypanosoma cruzi.
Mathieu-Daudé F; Lafay B; Touzet O; Lelièvre J; Parrado F; Bosseno MF; Rojas AM; Fatha S; Ouaissi A; Brenière SF
Infect Genet Evol; 2008 May; 8(3):258-66. PubMed ID: 18296127
[TBL] [Abstract][Full Text] [Related]
17. Disruption of Active Trans-Sialidase Genes Impairs Egress from Mammalian Host Cells and Generates Highly Attenuated Trypanosoma cruzi Parasites.
Burle-Caldas GA; Dos Santos NSA; de Castro JT; Mugge FLB; Grazielle-Silva V; Oliveira AER; Pereira MCA; Reis-Cunha JL; Dos Santos AC; Gomes DA; Bartholomeu DC; Moretti NS; Schenkman S; Gazzinelli RT; Teixeira SMR
mBio; 2022 Feb; 13(1):e0347821. PubMed ID: 35073735
[TBL] [Abstract][Full Text] [Related]
18. Heterologous expression of Trypanosoma cruzi trans-sialidase in Leishmania major enhances virulence.
Belen Carrillo M; Gao W; Herrera M; Alroy J; Moore JB; Beverley SM; Pereira MA
Infect Immun; 2000 May; 68(5):2728-34. PubMed ID: 10768966
[TBL] [Abstract][Full Text] [Related]
19. Identification of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylation.
Muiá RP; Yu H; Prescher JA; Hellman U; Chen X; Bertozzi CR; Campetella O
Glycobiology; 2010 Jul; 20(7):833-42. PubMed ID: 20354005
[TBL] [Abstract][Full Text] [Related]
20. Developmentally-regulated virulence factors of Trypanosoma cruzi and their relationship to evasion of host defences.
Hall BF; Joiner KA
J Eukaryot Microbiol; 1993; 40(2):207-13. PubMed ID: 8461894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
